美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bicara Therapeutics

15.51

+1.6912.23%

盘后：15.510.00000.00%17:52 EDT

成交量：117.58万

成交额：1,807.42万

市值：8.46亿

市盈率：-3.83

高：16.22

开：14.10

低：13.66

收：13.82

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Bicara Therapeutics

交易所：

NASDAQ

成立时间：

2018

员工人数：

55

公司地址：

116 Huntington Avenue,Suite 703,Boston,Massachusetts,United States

官网：

http://www.bicara.com

邮编：

02116

电话：

传真：

- -

简介：

Bicara Therapeutics Inc.于2018年12月12日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，致力于为实体瘤患者带来变革性的双功能疗法。他们的主要项目阿法是一种双功能抗体，它结合了两个临床验证的靶点，即表皮生长因子受体（EGFR）导向的单克隆抗体和结合人类转化生长因子β（TGF-b）的结构域。通过这种双靶向机制，阿法有可能通过同时阻断癌症细胞固有的EGFR存活和增殖，以及肿瘤微环境（TME）中的免疫抑制性TGF-b信号传导，发挥强大的抗肿瘤活性。Ficerafusp alfa通过与肿瘤细胞上的EGFR结合，将TGF-b抑制剂直接引入TME，他们认为这将导致持久的反应和总生存率或OS的增加，同时减少通常与全身TGF-b抑制相关的不良反应。

董事

名称

职位

Claire Mazumdar

Chief Executive Officer and Director

Michael Powell

Chairperson of the Board

Ryan Cohlhepp, Pharm.D

President, Chief Operating Officer and Director

Carolyn Ng

Director

Christopher Bowden

Director

Heath Lukatch

Director

Jake Simson

Director

Kate Haviland

Director

Kiran Mazumdar Shaw

Director

Nils Lonberg

Director

Scott Robertson

Director

Vijay Kuchroo, D.V.M

Director

股东

名称

职位

Claire Mazumdar

Chief Executive Officer and Director

Ryan Cohlhepp, Pharm.D

President, Chief Operating Officer and Director

Ivan Hyep

Chief Financial Officer

David Raben

Chief Medical Officer

Lara Meisner

Chief Legal Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BCAX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAX\",,,,,undefined,":{"symbol":"BCAX","market":"US","secType":"STK","nameCN":"Bicara Therapeutics","latestPrice":15.51,"timestamp":1745438400000,"preClose":13.82,"halted":0,"volume":1175828,"hourTrading":{"tag":"盘后","latestPrice":15.51,"preClose":15.51,"latestTime":"17:52 EDT","volume":1932,"amount":29933.8,"timestamp":1745445152974},"delay":0,"floatShares":28372221,"shares":54523326,"eps":-4.045991,"marketStatus":"已收盘","change":1.69,"latestTime":"04-23 16:00:00 EDT","open":14.1,"high":16.22,"low":13.66,"amount":18074200.123848,"amplitude":0.185239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.045991,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745481600000},"marketStatusCode":5,"adr":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":13.82,"preHourTrading":{"tag":"盘前","latestPrice":14.01,"preClose":13.82,"latestTime":"09:25 EDT","volume":38,"amount":531.089976,"timestamp":1745414717828},"postHourTrading":{"tag":"盘后","latestPrice":15.51,"preClose":15.51,"latestTime":"17:52 EDT","volume":1932,"amount":29933.8,"timestamp":1745445152974},"volumeRatio":2.551526,"impliedVol":0.5801,"impliedVolPercentile":0.3917},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAX\",,,,,undefined,":{"symbol":"BCAX","floatShares":28372221,"roa":"-13.84%","roe":"-19.14%","lyrEps":-4.045991,"volumeRatio":2.551526,"shares":54523326,"dividePrice":0,"high":16.22,"amplitude":0.185239,"preClose":13.82,"low":13.66,"week52Low":8.91,"pbRate":"1.72","week52High":28.09,"institutionHeld":0,"latestPrice":15.51,"eps":-4.045991,"divideRate":0,"volume":1175828,"delay":0,"ttmEps":-4.045991,"open":14.1,"prevYearClose":17.42,"prevWeekClose":12.16,"prevMonthClose":13.03,"prevQuarterClose":13.03,"fiveDayClose":11.45,"twentyDayClose":13.03,"sixtyDayClose":11.65},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":674698236,"yearFounded":2018,"employeeNum":55,"address":"116 Huntington Avenue,Suite 703,Boston,Massachusetts,United States","zipCode":"02116","officePhone":"617 468 4219"},"stockCompanyDetail":{"websiteUrl":"http://www.bicara.com","stockEarnings":[{"period":"1week","weight":0.207},{"period":"1month","weight":0.0438},{"period":"3month","weight":0.1594},{"period":"6month","weight":-0.3888},{"period":"1year","weight":-0.2322},{"period":"ytd","weight":-0.2067}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bicara Therapeutics Inc.于2018年12月12日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，致力于为实体瘤患者带来变革性的双功能疗法。他们的主要项目阿法是一种双功能抗体，它结合了两个临床验证的靶点，即表皮生长因子受体（EGFR）导向的单克隆抗体和结合人类转化生长因子β（TGF-b）的结构域。通过这种双靶向机制，阿法有可能通过同时阻断癌症细胞固有的EGFR存活和增殖，以及肿瘤微环境（TME）中的免疫抑制性TGF-b信号传导，发挥强大的抗肿瘤活性。Ficerafusp alfa通过与肿瘤细胞上的EGFR结合，将TGF-b抑制剂直接引入TME，他们认为这将导致持久的反应和总生存率或OS的增加，同时减少通常与全身TGF-b抑制相关的不良反应。","exchange":"NASDAQ","name":"Bicara Therapeutics","nameEN":"Bicara Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BCAX\",market:\"US\",,,undefined,":{"directors":[{"name":"Claire Mazumdar","position":"Chief Executive Officer and Director"},{"name":"Michael Powell","position":"Chairperson of the Board"},{"name":"Ryan Cohlhepp, Pharm.D","position":"President, Chief Operating Officer and Director"},{"name":"Carolyn Ng","position":"Director"},{"name":"Christopher Bowden","position":"Director"},{"name":"Heath Lukatch","position":"Director"},{"name":"Jake Simson","position":"Director"},{"name":"Kate Haviland","position":"Director"},{"name":"Kiran Mazumdar Shaw","position":"Director"},{"name":"Nils Lonberg","position":"Director"},{"name":"Scott Robertson","position":"Director"},{"name":"Vijay Kuchroo, D.V.M","position":"Director"}],"executives":[{"name":"Claire Mazumdar","position":"Chief Executive Officer and Director"},{"name":"Ryan Cohlhepp, Pharm.D","position":"President, Chief Operating Officer and Director"},{"name":"Ivan Hyep","position":"Chief Financial Officer"},{"name":"David Raben","position":"Chief Medical Officer"},{"name":"Lara Meisner","position":"Chief Legal Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"BCAX","fiscalQuarterEnding":"2024/12","expectedEps":-0.31,"name":null,"time":"盘前","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2024-11-12","symbol":"BCAX","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.5714,"hold":0,"sell":0.1429,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1744948800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCAX","date":"2025-04-22","current":-10.143688,"percent":0.926667,"low":-22.704836,"twenty":-19.02049,"median":-15.187116,"eighty":-11.307997,"high":-7.513546,"avg":-15.089006,"sd":3.993303,"marketCap":689720073},"quantilePoints":[{"date":"2024-09-13","current":-12.837909,"twenty":-12.837909,"median":-12.837909,"eighty":-12.837909,"marketCap":832435719},{"date":"2024-09-20","current":-20.633135,"twenty":-21.391361,"median":-20.283845,"eighty":-14.007791,"marketCap":1337893755},{"date":"2024-09-27","current":-21.555755,"twenty":-21.594337,"median":-21.446718,"eighty":-19.006626,"marketCap":1397718272},{"date":"2024-10-04","current":-19.962139,"twenty":-21.575885,"median":-21.337681,"eighty":-19.559541,"marketCap":1294385015},{"date":"2024-10-11","current":-15.936161,"twenty":-21.540658,"median":-20.570229,"eighty":-18.732598,"marketCap":1033332575},{"date":"2024-10-18","current":-17.143955,"twenty":-21.466848,"median":-20.283845,"eighty":-16.808457,"marketCap":1111648307},{"date":"2024-10-25","current":-18.964032,"twenty":-21.403103,"median":-19.23243,"eighty":-16.959431,"marketCap":1229665764},{"date":"2024-10-31","current":-19.878264,"twenty":-21.362844,"median":-19.23243,"eighty":-17.02653,"marketCap":1288946422},{"date":"2024-11-08","current":-19.79439,"twenty":-21.337681,"median":-19.82794,"eighty":-17.143955,"marketCap":1283507830},{"date":"2024-11-15","current":-20.345116,"twenty":-21.127995,"median":-19.949558,"eighty":-18.418848,"marketCap":1210086831},{"date":"2024-11-22","current":-16.257533,"twenty":-21.102833,"median":-19.82794,"eighty":-17.143955,"marketCap":966965549},{"date":"2024-11-29","current":-19.02049,"twenty":-20.975343,"median":-19.458892,"eighty":-17.009755,"marketCap":1131300719},{"date":"2024-12-06","current":-17.876882,"twenty":-20.695202,"median":-19.01323,"eighty":-17.12047,"marketCap":1063281195},{"date":"2024-12-13","current":-16.509127,"twenty":-20.532485,"median":-19.005969,"eighty":-17.12047,"marketCap":981929844},{"date":"2024-12-20","current":-15.187116,"twenty":-20.493904,"median":-18.892739,"eighty":-16.769874,"marketCap":903299275},{"date":"2024-12-27","current":-17.49263,"twenty":-20.458153,"median":-18.854995,"eighty":-16.764842,"marketCap":1040426635},{"date":"2025-01-03","current":-15.484454,"twenty":-20.399979,"median":-18.727694,"eighty":-16.641786,"marketCap":920984351},{"date":"2025-01-10","current":-13.952019,"twenty":-20.332862,"median":-18.565256,"eighty":-16.325863,"marketCap":829838189},{"date":"2025-01-17","current":-10.868852,"twenty":-20.271506,"median":-18.306879,"eighty":-15.951961,"marketCap":646457553},{"date":"2025-01-24","current":-10.951191,"twenty":-20.22215,"median":-18.224539,"eighty":-15.55307,"marketCap":651354959},{"date":"2025-01-31","current":-11.811185,"twenty":-20.138275,"median":-17.666458,"eighty":-14.949245,"marketCap":702505641},{"date":"2025-02-07","current":-11.52757,"twenty":-20.11652,"median":-17.561246,"eighty":-13.156068,"marketCap":685636799},{"date":"2025-02-14","current":-12.003311,"twenty":-19.978914,"median":-17.49263,"eighty":-12.003311,"marketCap":713932921},{"date":"2025-02-21","current":-12.643731,"twenty":-19.965494,"median":-17.085242,"eighty":-11.997822,"marketCap":752023854},{"date":"2025-02-28","current":-11.307997,"twenty":-19.942009,"median":-16.815614,"eighty":-11.891694,"marketCap":672577050},{"date":"2025-03-07","current":-14.409462,"twenty":-19.890007,"median":-16.73236,"eighty":-11.891694,"marketCap":857045999},{"date":"2025-03-14","current":-12.213735,"twenty":-19.838005,"median":-16.60519,"eighty":-11.893524,"marketCap":726448513},{"date":"2025-03-21","current":-11.975864,"twenty":-19.8011,"median":-16.394587,"eighty":-11.882546,"marketCap":712300452},{"date":"2025-03-28","current":-10.745093,"twenty":-19.525992,"median":-16.092853,"eighty":-11.882546,"marketCap":730612568},{"date":"2025-04-04","current":-9.486153,"twenty":-19.364339,"median":-15.936742,"eighty":-11.721526,"marketCap":645010946},{"date":"2025-04-11","current":-8.139007,"twenty":-19.311424,"median":-15.55307,"eighty":-11.500123,"marketCap":553411758},{"date":"2025-04-17","current":-9.430022,"twenty":-19.133936,"median":-15.269456,"eighty":-11.355571,"marketCap":641194313},{"date":"2025-04-22","current":-10.143688,"twenty":-19.02049,"median":-15.187116,"eighty":-11.307997,"marketCap":689720073}],"updateTime":1745462389309}}}